Identity
- Security key
- 13538
- Ticker
- CMPS
- Type
- ADRC — American Depository Receipt Common
- Exchange
- Nasdaq(XNAS)
- Venue group
- NASDAQ
- Operating MIC
- XNAS
- Market
- stocks
- Locale
- us
- Currency
- USD
- Listed
- 2020-09-18
- Round lot
- 100
- Active
- Yes
- Last seen in a load
- 2026-08-14 20:49
- Vendor updated
- 2026-08-13 06:09
- Ticker root / suffix
- CMPS
Detail
Enriched 2026-08-14 20:47
- Market cap
- $1,969,140,408.84
- Shares outstanding (class)
- 134,949,320
- Shares outstanding (weighted)
- 138,476,822
- SIC
- 2834 PHARMACEUTICAL PREPARATIONS
- Employees
- 156
- Location
- CHESIRE, X0
- Homepage
- https://compasspathways.com
- Description
Compass Pathways PLC is a biotechnology company focused on developing therapies for mental health conditions. Its research centers on a proprietary synthetic psilocybin formulation, COMP360, which is administered alongside psychological support. The company is conducting clinical trials to evaluate the safety and efficacy of this treatment in patients with treatment-resistant depression and other mental health disorders. The company operates in one operating segment.